Qimin Zheng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.
Journal: Kidney360
Published: August 21, 2025
Progress in therapeutic targets on podocyte for Alport syndrome.
Journal: Journal of translational internal medicine
Published: May 30, 2024
Clinical Characteristics and Prognosis of Genetic Focal Segment Glomerulosclerosis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: November 08, 2023
Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.
Journal: Kidney international
Published: September 09, 2023
Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis.
Journal: Clinical kidney journal
Published: February 07, 2023
COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2.
Journal: Kidney international reports
Published: September 27, 2022
Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: February 20, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026